[Paraneoplastic endocrinopathies].
D000324:Adrenocorticotropic Hormone / Q000378:metabolism; D001477:Bartter Syndrome / Q000503:physiopathology; D002116:Calcitonin / Q000378:metabolism; D002822:Choriocarcinoma / Q000378:metabolism; D003346:Corticotropin-Releasing Hormone / Q000378:metabolism; D004921:Erythropoietin / Q000378:metabolism; D005260:Female; D006062:Gonadotropins / Q000378:metabolism; D006801:Humans; D006934:Hypercalcemia / Q000209:etiology; D007003:Hypoglycemia / Q000209:etiology; D008297:Male; D009384:Paraneoplastic Endocrine Syndromes / Q000503:physiopathology*; D010257:Paraneoplastic Syndromes / Q000473:pathology*; D011247:Pregnancy; D011388:Prolactin / Q000378:metabolism; D012083:Renin / Q000378:metabolism; D012097:Repressor Proteins; D013724:Teratoma / Q000378:metabolism; D013736:Testicular Neoplasms / Q000378:metabolism; D013972:Thyrotropin / Q000378:metabolism
D006062:Gonadotropins; D012097:Repressor Proteins; D004921:Erythropoietin; D000324:Adrenocorticotropic Hormone; D011388:Prolactin; D013972:Thyrotropin; D002116:Calcitonin; D003346:Corticotropin-Releasing Hormone; D012083:Renin
Paraneoplastische Endokrinopathien.